Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kjekshus

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Circulation. Heart Failure|January 11, 2011
Osteoprotegerin predicts progression of chronic heart failure: results from CORONAThor Ueland, Christen P Dahl, John Kjekshus, et al.
Cardiovascular Research|June 14, 2005
Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodelingDevorah Gurantz, Arne Yndestad, Bente Halvorsen, et al.
International Journal of Cardiology|May 30, 2013
Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failureChristen Peder Dahl, Pål Aukrust, Ståle H Nymo, et al.
Plos One|August 20, 2015
Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Erik Tandberg Askevold, Lars Gullestad, Ståle Nymo, et al.
Cardiology|November 28, 2014
Predictive value of endostatin in chronic heart failure patients with poor kidney functionThor Ueland, Pål Aukrust, Ståle H Nymo, et al.
European Journal of Heart Failure|February 4, 2012
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiologyKaspar Broch, Thor Ueland, Ståle H Nymo, et al.
American Heart Journal|January 22, 2005
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HFPrakash C Deedwania, Thomas D Giles, Michael Klibaner, et al.
International Journal of Cardiology|October 2, 2017
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiativeStefan Agewall, Lars H Tjessem, Patrick Rossignol, et al.
European Journal of Heart Failure|March 29, 2006
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF StudyDirk J van Veldhuisen, Halfdan Aass, Dia El Allaf, et al.
Circulation. Heart Failure|December 12, 2012
Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Erik Tandberg Askevold, Ståle Nymo, Thor Ueland, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Circulation. Heart Failure|January 11, 2011
Osteoprotegerin predicts progression of chronic heart failure: results from CORONAThor Ueland, Christen P Dahl, John Kjekshus, et al.
Cardiovascular Research|June 14, 2005
Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodelingDevorah Gurantz, Arne Yndestad, Bente Halvorsen, et al.
International Journal of Cardiology|May 30, 2013
Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failureChristen Peder Dahl, Pål Aukrust, Ståle H Nymo, et al.
Plos One|August 20, 2015
Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Erik Tandberg Askevold, Lars Gullestad, Ståle Nymo, et al.
Cardiology|November 28, 2014
Predictive value of endostatin in chronic heart failure patients with poor kidney functionThor Ueland, Pål Aukrust, Ståle H Nymo, et al.
European Journal of Heart Failure|February 4, 2012
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiologyKaspar Broch, Thor Ueland, Ståle H Nymo, et al.
American Heart Journal|January 22, 2005
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HFPrakash C Deedwania, Thomas D Giles, Michael Klibaner, et al.
International Journal of Cardiology|October 2, 2017
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiativeStefan Agewall, Lars H Tjessem, Patrick Rossignol, et al.
European Journal of Heart Failure|March 29, 2006
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF StudyDirk J van Veldhuisen, Halfdan Aass, Dia El Allaf, et al.
Circulation. Heart Failure|December 12, 2012
Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Erik Tandberg Askevold, Ståle Nymo, Thor Ueland, et al.
Pageof 12